Pinto Joshua
Insider CIK 1992595 · NMRA President & CEO, Director · MTSR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 5,967 | $3.54 | $21.1K | 57,783 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-01-08 | 2026-01-09 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 148,953 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 2,688 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 16,125 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 720,084 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 223,034 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 270,828 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 223,034 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 170,000 | — | $0 | 170,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 127,448 | — | $0 | 127,448 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 720,084 | — | $0 | 720,084 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 223,034 | — | $0 | 223,034 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 270,828 | — | $0 | 270,828 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 223,034 | — | $0 | 223,034 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 3,000,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 170,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 127,448 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | G Gift deriv | 2025-05-22 | 2025-05-22 | 148,953 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | G Gift deriv | 2025-05-22 | 2025-05-22 | 148,953 | — | $0 | 148,953 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2025-05-21 | 2025-05-23 | 13,202 | — | $0 | 152,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2025-05-21 | 2025-05-23 | 13,202 | — | $0 | 63,750 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-05-20 | 2025-05-22 | 16,125 | — | $0 | 16,125 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 8,048 | $1.67 | $13.4K | 76,952 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 270,828 | — | $0 | 270,828 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 223,034 | — | $0 | 223,034 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 170,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 127,448 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 720,084 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 223,034 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 170,000 | — | $0 | 170,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 223,034 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 223,034 | — | $0 | 223,034 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 720,084 | — | $0 | 720,084 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 127,448 | — | $0 | 127,448 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 270,828 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-27 | 15,693 | $11.39 | $178.7K | 138,965 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-26 | 31,642 | $11.78 | $372.7K | 154,658 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-08-23 | 2024-08-26 | 24,169 | $11.59 | $280.1K | 186,300 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-08-22 | 2024-08-26 | 28,496 | $11.63 | $331.4K | 210,469 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2024-04-17 | 2024-06-28 | 238,965 | — | $0 | 238,965 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 170,000 | — | $0 | 170,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-16 | 85,000 | — | $0 | 323,965 | SEC↗ |